Investigation of cardiac adverse effects in COVID-19 ARDS patients treated with intravenous immunoglobulin.

Objective: The popularity of intravenous immunoglobulin (IVIG) therapy in Acute Respiratory Distress Syndrome (CARDS) secondary to COVID-19 infection is increasing day by day. In this study, we aimed to retrospectively evaluate the possible cardiac effects in our CARDS patients treated with IVIG.

Methods: Demographic and clinical characteristics, mortality, sequential electrocardiography (ECG), echocardiography, cardiac markers, and other laboratory parameters of CARDS patients who received IVIG treatment were recorded.

Investigation of mortality rates and the factors affecting survival in out-of-hospital cardiac arrest patients.

Background: It is known that even if spontaneous circulation returns after cardiopulmonary resuscitation(CPR) in geriatric out-of-hospital cardiac arrests(OHCA), the overall one-year survival rate of these patients is very low. In our study, we aimed to investigate the factors affecting survival in OHCA cases.

Methods: OHCA patients over 18 years of age were examined in two different groups as 18-64 years old and over 65 years old.